Neuland Laboratories reported an uptick in peptide-related engagements from Japanese companies, particularly at the preclinical and early clinical stages
C. P. Radhakrishnan urged graduates to uphold ethical standards and maintain a commitment to patient care
The company announced that its Phase III FENhance 1 and 2 studies both met their primary endpoints
SBE303 targets Nectin-4, an adhesion protein overexpressed in multiple tumor types, including urothelial, lung, and breast cancers
The newly formed SAB will provide strategic direction across research, clinical development, and regulatory pathways
Revvity is positioning its technologies as a connected engine for discovery
Through the partnership, she plans to share her experience—from consultation through recovery—across her social media platforms
TheraNym will set up a greenfield large-scale mammalian drug substance manufacturing facility
CDSCO-approved therapy enters India’s fast-growing post-patent GLP-1 market with fully integrated API, formulation and pen manufacturing
Backed by funding from an NIHR Doctoral Award, the guidance is focused on spotting abdominal tumours
Subscribe To Our Newsletter & Stay Updated
